Leica Biosystems, founded 1872 as Precision Engineering,[1] is a medical device company that develops and supplies clinical diagnostics to the pathology market. It is also a research, instrument, and medical device company and a division of Danaher Corporation.
Company Description
The company is headquartered in Germany, with operations in the United Kingdom, Netherlands, Australia, India, China, Singapore, Mexico, and the United States (California, Illinois, and Ohio). A research and development facility concentrating on companion diagnostics for cancer drugs has been in operation in Danvers, Massachusetts since August 2012.[2] The Massachusetts facility has partnered with Galena Biopharma to develop companion diagnostics for a breast cancer vaccine.[3]
In 2024, Leica Biosystems announced the relocation of its Companion Diagnostics and Advanced Assays business to Newcastle, United Kingdom.